Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Tissue Repair Ltd

Healthcare AU TRP

0.165AUD
0.005(3.12%)

Last update at 2026-03-11T04:50:00Z

Day Range

0.170.17
LowHigh

52 Week Range

0.150.48
LowHigh

Fundamentals

  • Previous Close 0.16
  • Market Cap9.98M
  • Volume16310
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-4.72150M
  • Revenue TTM2.63M
  • Revenue Per Share TTM0.04
  • Gross Profit TTM 2.63M
  • Diluted EPS TTM-0.06

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -4.23850M -4.13810M -4.17441M -6.83759M -0.91523M
Minority interest - - - - -
Net income -4.23850M -4.13810M -4.17441M -6.83759M -0.91523M
Selling general administrative 1.51M 2.39M 1.18M 1.87M 0.06M
Selling and marketing expenses 0.88M 0.27M - - -
Gross profit 2.63M 0.15M 0.00308M - -
Reconciled depreciation - 0.00173M 0.00265M 0.00171M -
Ebit -4.82531M -6.51630M -4.77175M -6.83759M -0.48853M
Ebitda -4.72150M -6.51457M -5.73768M -6.83587M -
Depreciation and amortization 0.10M 0.00173M - 0.00171M -
Non operating income net other - - - - -
Operating income -4.72150M -6.51630M -4.77175M -6.83759M -0.55337M
Other operating expenses 7.35M 6.67M - 5.45M -
Interest expense - - - 0.00000M -
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.20M 0.74M 0.60M 0.04M 0.36M
Net interest income - 0.74M 0.43M 0.04M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - -1.63862M - -1.42871M -
Total revenue 2.63M 0.15M 0.00308M 0.00000M 0.00000M
Total operating expenses 7.35M 6.67M - 5.45M -
Cost of revenue - 0.00173M - - -
Total other income expense net 0.48M 0.74M 1.14M -1.42871M -
Discontinued operations - - - - -
Net income from continuing ops - -4.13810M -4.17441M -6.83759M -
Net income applicable to common shares -4.23850M -4.13810M -4.17441M -6.83759M -0.91523M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 14.57M 19.39M 22.38M 25.90M 27.61M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.20M 0.20M 0.02M 0.06M 0.00500M
Total liab 0.66M 1.35M 0.50M 0.56M 0.54M
Total stockholder equity 13.91M 18.04M 21.88M 25.34M 27.07M
Deferred long term liab - - - - -
Other current liab 0.38M 0.70M 0.03M 0.36M 0.00200M
Common stock 35.04M 35.04M 35.04M 35.04M 33.06M
Capital stock - - 35.04M 35.04M 33.06M
Retained earnings -23.18069M -18.94218M -14.80408M -10.62967M -6.05100M
Other liab - - 0.00655M 0.00086M -
Good will - - - - -
Other assets - - - - -
Cash 12.32M 16.44M 21.40M 25.46M 27.11M
Cash and equivalents - - - - -
Total current liabilities 0.64M 1.34M 0.49M 0.56M 0.54M
Current deferred revenue - - - - -
Net debt -12.31848M -16.44105M - -25.45529M -27.11100M
Short term debt - - 0.00000M 0.00000M 0.00000M
Short long term debt - - - - -
Short long term debt total - - - - -
Other stockholder equity - - 1.65M 0.93M 0.06M
Property plant equipment - - 0.00181M 0.00221M -
Total current assets 14.25M 19.39M 22.38M 25.90M 27.61M
Long term investments - - - - -
Net tangible assets - - 21.88M 25.34M 0.09M
Short term investments - - - - -
Net receivables 1.74M 2.53M 0.83M 0.05M 0.05M
Long term debt - - - 0.00000M 7.50M
Inventory 0.00039M 0.21M 0.02M - 0.44M
Accounts payable 0.26M 0.64M 0.08M 0.20M 0.53M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 2.05M 1.94M - 0.93M 0.06M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.00000M - - -
Deferred long term asset charges - - - - -
Non current assets total 0.32M 0.00343M 0.00181M 0.00221M 0.00000M
Capital lease obligations - - - - -
Long term debt total - - 0.00000M 0.00000M 7.50M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments - -0.00335M -0.00224M -0.00392M 0.00500M
Change to liabilities - - -0.10293M 0.01M 0.15M
Total cashflows from investing activities -0.42167M -0.00335M -0.00224M -0.00392M 0.00500M
Net borrowings - - - - 7.50M
Total cash from financing activities 0.00000M 0.00000M 0.00000M 21.36M 7.46M
Change to operating activities - - -0.02772M -0.07526M 0.00872M
Net income -4.23850M -4.13810M -4.17441M -6.83759M -0.91523M
Change in cash -4.12258M -4.95541M -4.05883M 17.69M 6.62M
Begin period cash flow 16.44M 21.40M 25.46M 7.76M -
End period cash flow 12.32M 16.44M 21.40M 25.46M 7.76M
Total cash from operating activities -3.69911M -4.95121M -4.25546M -3.96615M -0.85289M
Issuance of capital stock - - - 22.00M -
Depreciation 0.10M 0.00173M 0.00265M 0.00171M 0.00171M
Other cashflows from investing activities - - - 0.00000M 0.00500M
Dividends paid - - - - -
Change to inventory 0.21M -0.19444M -0.02029M -0.02029M -0.02029M
Change to account receivables 0.74M -1.69829M -0.45203M 0.00616M -0.17336M
Sale purchase of stock - - 0.00000M -0.63884M 0.00000M
Other cashflows from financing activities 0.00000M -0.00335M 0.00000M -0.00392M -0.03507M
Change to netincome - - 0.52M 2.93M 0.07M
Capital expenditures 0.42M 0.00335M 0.00224M 0.00392M 0.00392M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.70M -1.11079M 0.42M 0.01M 0.00118M
Stock based compensation 0.11M 0.30M - - -
Other non cash items -0.38232M 0.30M - - -
Free cash flow -4.12078M -4.95457M -4.25770M -0.00392M -

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
TRP
Tissue Repair Ltd		 0.005 3.12% 0.17 - - 3.79 0.67 4.87 1.96
CSL
CSL Ltd		 -1.98 1.37% 142.58 16.70 19.49 4.61 2.68 3.87 11.63
TLX
TELIX Pharmaceuticals Ltd		 -0.24 2.18% 10.76 - 1000.00 4.25 5.68 3.34 76.39
MSB
Mesoblast Ltd		 0.01 0.46% 2.19 - 454.55 43.02 3.19 28.08 -9.8623
NEU
Neuren Pharmaceuticals Ltd		 -0.2 1.57% 12.55 53.70 45.66 24.19 4.61 19.56 57.40

Reports Covered

Stock Research & News

View All

Profile

Tissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. The company utilizes Glucoprime technology, an immunogenic active pharmaceutical ingredient that activates macrophages and stimulates immune response for wound healing and skin regeneration. It develops TR-987, a topical drug in Phase III clinical trial for the treatment of chronic wounds and venous leg ulcers; and TR Pro+, a post-procedure gel for the aftercare of acute wounds, and aesthetic and medical procedures. Tissue Repair Ltd was incorporated in 2012 and is based in Chatswood, Australia.

Tissue Repair Ltd

Tower A, The Zenith, Chatswood, NSW, Australia, 2067

Key Executives

Name Title Year Born
Mr. Tony Charara Co-Founder & Exec. Director NA
Mr. Cameron Jones C.A. Chief Financial Officer NA
Dr. Darryl Reed Chief Operating Officer NA
Mr. Michael Austin Company Sec. NA
Ms. Priyamvada Sanjay Rasal Company Secretary NA
Mr. Tony Charara Co-Founder & Executive Director NA
Mr. Tony Charara Co-Founder & Executive Director NA
Mr. Tony Charara Co-Founder & Executive Director NA
Ms. Priyamvada Sanjay Rasal Company Secretary NA
Mr. Tony Charara Co-Founder & Executive Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.